Adam Lee
About Adam Lee
Adam Lee is the Director Worldwide HEOR Markets Oncology at Bristol Myers Squibb in London, with over a decade of experience in health economics and outcomes research.
Title
Adam Lee is the Director of Worldwide Health Economics and Outcomes Research (HEOR) Markets Oncology at Bristol Myers Squibb.
Current Role at Bristol Myers Squibb
Adam Lee currently serves as the Director of Worldwide HEOR Markets Oncology at Bristol Myers Squibb in London, England, United Kingdom. He assumed this position in August 2021. His role focuses on the oncology segment within the field of health economics and outcomes research.
Previous Role at Novartis
Before joining Bristol Myers Squibb, Adam Lee worked at Novartis as a Health Economics and Outcomes Research Manager in Basel, Basel-City, Switzerland. His work at Novartis also concentrated on oncology markets, where he gained extensive experience in health economics.
Education and Expertise
Adam Lee has a robust academic background. He earned a Master of Science (MSc) in Health Economics from City University London, where he studied from 2009 to 2011. Prior to that, he obtained a Bachelor of Arts (B.A.) in Economics from Kingston University, completing his undergraduate studies from 2006 to 2009. These qualifications have equipped him with a strong foundation in health economics.
Experience in Health Economics
Adam Lee has over a decade of experience in health economics and outcomes research. He specializes in oncology markets, applying his extensive knowledge and skills within this specialized field to impact healthcare strategies and outcomes.